Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Literature DB >> 24839253

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Hashem B El-Serag¹, Fasiha Kanwal.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2014 PMID： 24839253 PMCID： PMC4211957 DOI： 10.1002/hep.27222

Source DB: PubMed Journal: Hepatology ISSN： 0270-9139 Impact factor: 17.425

× No keyword cloud information.

56 in total

1. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

Authors: M H Chang; C J Chen; M S Lai; H M Hsu; T C Wu; M S Kong; D C Liang; W Y Shau; D S Chen
Journal: N Engl J Med Date: 1997-06-26 Impact factor: 91.245

2. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis.

Authors: Sharon J Hutchinson; Sheila M Bird; David J Goldberg
Journal: Clin Gastroenterol Hepatol Date: 2005-11 Impact factor: 11.382

3. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.

Authors: M W Yu; Y C Yang; S Y Yang; S W Cheng; Y F Liaw; S M Lin; C J Chen
Journal: J Natl Cancer Inst Date: 2001-11-07 Impact factor: 13.506

Review 4. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors: Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal: Gastroenterology Date: 2004-11 Impact factor: 22.682

5. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women.

Authors: F Donato; A Tagger; U Gelatti; G Parrinello; P Boffetta; A Albertini; A Decarli; P Trevisi; M L Ribero; C Martelli; S Porru; G Nardi
Journal: Am J Epidemiol Date: 2002-02-15 Impact factor: 4.897

6. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma.

Authors: Yen-Hsuan Ni; Mei-Hwei Chang; Kuan-Jan Wang; Hong-Yuan Hsu; Huey-Ling Chen; Jia-Horng Kao; Shiou-Hwei Yeh; Yung-Ming Jeng; Keh-Sung Tsai; Ding-Shinn Chen
Journal: Gastroenterology Date: 2004-12 Impact factor: 22.682

7. Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors: Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal: N Engl J Med Date: 2004-10-07 Impact factor: 91.245

8. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

Authors: Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal: Gastroenterology Date: 2003-02 Impact factor: 22.682

9. Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis.

Authors: Shiou-Hwei Yeh; Ching-Fung Chang; Wen-Yi Shau; Ya-Wen Chen; Hey-Chi Hsu; Po-Huang Lee; Ding-Shinn Chen; Pei-Jer Chen
Journal: Cancer Res Date: 2002-08-01 Impact factor: 12.701

10. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China.

Authors: J Shi; L Zhu; S Liu; W-F Xie
Journal: Br J Cancer Date: 2005-02-14 Impact factor: 7.640

226 in total

1. Effect of travel distance and rurality of residence on initial surveillance for hepatocellular carcinoma in VA primary care patient with cirrhosis.

Authors: Yolanda Rodriguez Villalvazo; Jennifer S McDanel; Lauren A Beste; Antonio J Sanchez; Mary Vaughan-Sarrazin; David A Katz
Journal: Health Serv Res Date: 2019-11-25 Impact factor: 3.402

Review 2. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.

Authors: Kerstin Schütte; Christian Schulz; Alexander Link; Peter Malfertheiner
Journal: World J Hepatol Date: 2015-02-27

3. Cyproheptadine use in hepatocellular carcinoma.

Authors: Mao-Chih Hsieh; Wei-Hua Lee; Alexander Th Wu; Jyh-Ming Chow; Chia-Lun Chang; Kevin Sheng-Po Yuan; Szu-Yuan Wu
Journal: Am J Cancer Res Date: 2017-03-01 Impact factor: 6.166

4. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.

Authors: Awalpreet S Chadha; Jillian R Gunther; Cheng-En Hsieh; Maureen Aliru; Lakshmi S Mahadevan; Bhanu P Venkatesulu; Christopher H Crane; Prajnan Das; Joseph M Herman; Eugene J Koay; Cullen Taniguchi; Emma B Holliday; Bruce D Minsky; Yelin Suh; Peter Park; Gabriel Sawakuchi; Sam Beddar; Bruno C Odisio; Sanjay Gupta; Evelyne Loyer; Harmeet Kaur; Kanwal Raghav; Milind M Javle; Ahmed O Kaseb; Sunil Krishnan
Journal: Radiother Oncol Date: 2019-01-16 Impact factor: 6.280

5. Monitoring the hepatitis C care cascade using administrative claims data.

Authors: Cheryl Isenhour; Susan Hariri; Claudia Vellozzi
Journal: Am J Manag Care Date: 2018-05 Impact factor: 2.229

6. Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014.

Authors: Ryung S Kim; Andrea H Weinberger; Geetanjali Chander; Mark S Sulkowski; Brianna Norton; Jonathan Shuter
Journal: Am J Med Date: 2018-01-31 Impact factor: 4.965

7. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?

Authors: Stefanie J Hectors; Mathilde Wagner; Cecilia Besa; Octavia Bane; Hadrien A Dyvorne; M Isabel Fiel; Hongfa Zhu; Michael Donovan; Bachir Taouli
Journal: J Magn Reson Imaging Date: 2016-02-26 Impact factor: 4.813